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Abstract
While	NLRP3‐inflammasome	has	been	implicated	in	cardiovascular	diseases,	its	role	
in physiological cardiac aging is largely unknown. During aging, many alterations 
occur in the organism, which are associated with progressive impairment of metabolic 
pathways related to insulin resistance, autophagy dysfunction, and inflammation. 
Here, we investigated the molecular mechanisms through which NLRP3 inhibition 
may	attenuate	cardiac	aging.	Ablation	of	NLRP3‐inflammasome	protected	mice	from	
age‐related	increased	insulin	sensitivity,	reduced	IGF‐1	and	leptin/adiponectin	ratio	
levels,	and	reduced	cardiac	damage	with	protection	of	the	prolongation	of	the	age‐
dependent PR interval, which is associated with atrial fibrillation by cardiovascular 
aging and reduced telomere shortening. Furthermore, old NLRP3 KO mice showed an 
inhibition	of	the	PI3K/AKT/mTOR	pathway	and	autophagy	improvement,	compared	
with	old	wild	mice	and	preserved	Nampt‐mediated	NAD+	levels	with	increased	SIRT1	
protein expression. These findings suggest that suppression of NLRP3 prevented 
many	age‐associated	changes	in	the	heart,	preserved	cardiac	function	of	aged	mice	
and increased lifespan.
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1  | INTRODUC TION
Cardiovascular	diseases	(CVD)	constitute	the	leading	cause	of	death	
worldwide,	with	high	prevalence	 in	 industrialized	and	 low‐	to	mid‐
dle‐income	 countries	 (Ford,	 Li,	 Zhao,	 Pearson,	&	Capewell,	 2009).	
Several	risk	factors	have	been	identified,	including	genetics,	hyper‐
tension,	 obesity,	 smoking,	 and	 physical	 inactivity.	 Secondary	 risk	
factors correlated with cardiovascular risk include insulin resistance 
and	lipid	profile	(Gómez‐Pardo	et	al.,	2016).	However,	aging,	a	nat‐
ural process, poses the largest risk factor for cardiovascular disease 
(Fontana, 2008). During aging, we suffer a progressive impairment 
of several metabolic pathways that define body composition, in‐
sulin resistance, mitochondrial and autophagy dysfunction, and in‐
flammation (Finkel, 2015). Many of these alterations are implicated 
in	 cardiac	 aging	 and	 age‐related	 cardiovascular	 diseases	 (North	&	
Sinclair,	2012).
Markers of inflammation have been associated with cardiovas‐
cular diseases and proposed as other cardiovascular risk factors 
(Bullón	et	al.,	2017).	Recently,	the	role	of	the	NLR	family	pyrin	do‐
main containing 3 protein (NLRP3) inflammasome has been studied 
in cardiovascular diseases. NLRP3 inflammasome is upregulated 
after myocardial infarction, atherosclerosis, ischemic heart disease, 
diabetic cardiomyopathy, chronic heart failure, and hypertension, 
and	recently,	NLRP3	and	IL‐1β have also been proposed as new car‐
diovascular	risk	biomarkers	(Bullón	et	al.,	2017;	Liu,	Zeng,	Li,	Mehta,	
&	Wang,	2017).	Previous	studies	have	suggested	a	role	for	NLRP3	
inflammasome	in	several	events	associated	with	aging.	Genetic	de‐
letion of NLRP3 in mice has been shown to improve healthspan by 
attenuation	of	multiple	 age‐related	degenerative	 changes,	 such	 as	
glycemic control, bone loss, cognitive function, and motor perfor‐
mance (Youm et al., 2013). Furthermore, the deletion of NLRP3 in old 
mice increased muscle strength and endurance and prevented from 
age‐related	increase	in	the	number	of	myopathic	fibers	(McBride	et	
al., 2017). However, the role of the NLRP3 inflammasome in lifespan 
and cardiac aging has not been studied. Hence, we sought to deter‐
mine whether or not genetic deletion of NLRP3 may have effect on 
lifespan and potentially prevent cardiac aging.
2  | RESULTS
2.1 | NLRP3 deletion improves lifespan and 
metabolic aging
To evaluate the impact of NLRP3 deletion on survival and metabolic 
changes	during	aging,	we	followed	NLRP3	deficient	(NLRP3	−/−)	and	
NLRP3	+/+	littermate	control	(WT)	mice	throughout	the	entire	lifes‐
pan.	The	survival	of	NLRP3	−/−	mice	compared	to	littermate	controls	
using a Kaplan–Meier survival curve was augmented with an increase 
in mean lifespan of 34% and in maximum lifespan of 29% (Figure 1a), 
while body weights and food intake did not differ between the two 
groups	 during	 the	 entire	 observation	 period	 (Figure	 1b,c).	 Twenty‐
four‐month‐old	WT	animals	displayed	increased	age‐related	alopecia	
than	 their	 coveal	NLRP3	knockout	mice	 (Figure	1d).	Old	NLRP3−/−	
mice	 exhibited	 a	 significant	 decrease	 in	 glucose	 at	 the	OGTT	 peak	
(>15	 min),	 compared	 with	 old	 WT	 mice	 (Figure	 1e,f),	 indicating	 a	
higher glucose tolerance as measured as a trend toward lower values 
of	the	area	under	the	curve	(AUC)	of	the	glucose	tolerance	test	 (in‐
sert	of	Figure	1f).	Fasting	blood	glucose	and	circulating	 IGF‐1	 levels	
were	 reduced	 in	young	and	old	NLRP3−/−	mice,	 indicating	 that	 the	
insulin sensitivity of these animals was considerably higher than sham 
controls	during	aging	(Table	S1).	Reduced	levels	of	glucose	and	IGF‐1	
have been associated with stress resistance and an antiaging effect 
(Brandhorst et al., 2015). Furthermore, leptin is an established regu‐
lator of body weight, and leptin/adiponectin dysregulation has been 
associated with cardiovascular disease, metabolic syndrome, and non‐
alcoholic	fatty	liver	disease	(DiNicolantonio,	Lucan,	&	O'Keefe,	2016).	
Young	and	old	NLRP3−/−	mice	showed	similar	serum	levels	of	leptin	
compared	to	young	and	old	WT,	but	a	reduced	leptin/adiponectin	ratio	
with	 increased	 levels	of	adiponectin	was	observed	 in	old	NLRP3−/−	
mice	(Figure	1g–i).	Plasma	lipid	levels	were	reduced	in	NLRP3−/−	old	
mice, accompanied by a significant reduction in hepatic transami‐
nases,	creatine	phosphokinase,	and	lactate	dehydrogenase	(Table	S1).	
However,	plasma	 IL‐1β levels were not detected in old mice, but in‐
creased	protein	levels	of	active	caspase	1	and	IL‐1β were observed in 
old	WT,	when	compared	to	NLRP3−/−	mice	(Figure	S1),	and	increased	
levels	of	TNF‐α,	IL‐6,	and	IL‐8	were	observed	in	WT	similar	old	mice	
and	NLRP3−/−	mice.	This	shows	that	the	loss	of	NLRP3	did	not	affect	
the	age‐related	increase	of	other	inflammatory	pathways	and	confers	
an	important	role	on	inflammasome	in	cardiac	aging	(Table	S1).
2.2 | NLRP3 deletion preserved cardiac integrity
Heart	weight	normalized	to	body	weight	was	increased	in	old	mice	in	
comparison	with	young	mice,	and	heart	weight	was	higher	 in	WT	in	
comparison	with	NLRP3−/−	(p	<	.05)	(Figure	2a	and	Table	S2).	Cardiac	
hypertrophy measured by the left ventricular wall thickness was sig‐
nificantly	increased	in	elderly	WT	when	compared	to	NLRP3−/−	mice	
which	was	corroborated	by	LV	mass	measured	by	echocardiography	
(Figure 2b). To assess the impact of aging and cardiac hypertrophy 
on	myocardial	histology,	the	cardiomyocyte	cross‐sectional	area	and	
fibrosis	 were	 quantified.	 In	 the	 hematoxylin‐and‐eosin–stained	 sec‐
tions,	aged	WT	mice	showed	an	increased	cardiomyocyte	transverse	
cross‐sectional	 area	 unlike	NLRP3−/−	mice	 (Figure	 2c,d),	which	was	
corroborated	by	wheat	 germ	agglutinin	 staining	 (Figure	S2).	 Further	
K E Y W O R D S
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examination	with	Masson	trichrome	and	Sirius	 red	staining	 revealed	
overt	interstitial	and	perivascular	fibrosis	in	the	aged	WT	group,	with	
no	 significant	 changes	 in	 the	 aged	 NLRP3−/−	 group	 (Figure	 2c,d).	
Ultrastructural	 analysis	 of	 the	 left	 ventricle	 in	 WT	 and	 NLRP3−/−	
showed	mitochondrial	 abnormalities.	We	 compared	 electron	micro‐
scopic	 images	 of	 cardiac	 tissues	 from	 young	 and	 old	WT	mice	 and	
NLRP3−/−	 mice.	 TEM	 studies	 revealed	 evidence	 of	 mitochondrial	
damage	 in	 aged	 WT	 myocardium,	 including	 mitochondrial	 disarray,	
degeneration, fragmentation, reduction of mitochondrial area, and 
cristae	disorganization,	that	is,.	pointing	in	varying	oblong	and	oblique	
directions	in	the	matrix	(Figures	S3a,b	and	S4a,b).
Upon	electrocardiographic	examination,	the	mean	QRS	complex	
was	not	significantly	wider	in	old	WT	mice;	however,	we	observed	a	
significant	prolongation	of	the	age‐dependent	PR	interval,	which	is	
F I G U R E  1   NLRP3 signaling suppression in mice extend lifespan and improve metabolic homeostasis. (a) Kaplan–Meier graph showing a 
significant	increment	of	the	máximum	lifespan	in	WT	mice	(blue)	compared	with	NLRP3	−/−	mice	(red).	(b,	c)	Body	weights	and	average	daily	
oral	food	intake	normalized	to	body	weight	and	to	mouse	of	the	groups	over	time.	Images	of	representative	mice	to	illustrate	phenotypic	
body mass of the groups at 20 months of age. (d) Representative photographs of 24 months of age mice. (e, f) Oral glucose tolerance test 
with area under the curve (inset). (g–i) Levels of leptin, adiponectin, and ratio in plasma. Blood samples were collected after overnight 
fasting.	All	data	are	presented	as	means	±	SEM, n = 10 mice; *p < .05, **p < .005, ***p < .001 young vs. old mice. aap	<	.005,	WT	vs.	NLRP3	
−/−	mice
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F I G U R E  2  NLRP3	signaling	suppression	in	mice	induces	cardiac	protection.	(a)	Heart	weight	normalized	to	body	weight.	(b)	
Representative	image	of	centripetal	concentric	LV	hypertrophy	(c)	Representative	Hematoxylin	and	eosin	(H&E)‐stained	section	(left)	
of	cardiac	tissues	from	young	and	old	WT	and	NLRP3	−/−	mice.	Representative	Masson	trichrome‐stained	section	(center)	and	Sirius	
red‐stained	section	(right).	(d)	Quantitative	analysis	of	cardiomyocyte	cross‐sectional	(transverse)	area	with	measurements	of	≈100	
cardiomyocytes and fibrotic areas from 3 to 6 mice per group. ***p < .001 young vs. old mice. aaap	<	.001,	WT	vs.	NLRP3	−/−	mice.	(e)	
Summary	of	differences	in	PR	and	QRS	intervals	in	young	and	aged	WT	vs.	NLRP3	−/−	mice.	All	data	are	presented	as	means	±	SEM, n = 10 
mice; *p < .05
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associated with atrial fibrillation by cardiovascular aging (Figure 2e) 
(Magnani et al., 2013). Due to the improvement in the cardiac func‐
tion of old KO mice and the low incidence of cancer in these mice 
(WT	showed	an	 increased	rate	of	hepatocarcinoma	and	adenocar‐
cinoma	at	death),	the	cause	of	death	was	unknown	and	will	require	
further study.
2.3 | Age‐associated metabolic changes were 
prevented in NLRP3−/−
In order to evaluate the role of NLRP3 during aging of the heart, 
several markers and pathways associated with aging were studied 
in	hearts	from	young	and	aged	WT	and	NLRP3−/−	mice.	Telomeres	
in	young	animals	were	similar	in	WT	and	NLRP3	−/−	mice,	whereas	
in	 two‐year‐old	 animals,	 NLRP3	 −/−	 mice	 showed	 slightly	 longer	
telomeres (Figure 3a,b). This is due to an increased telomere length 
reduction	rate	in	WT	mice	compared	with	NLRP3	−/−	mice	(Figure	
S5a).	 Furthermore,	 less	 lipofuscin	 accumulation	 in	 the	 heart	 of	
NLRP3−/−	mice	was	 shown	after	 a	qualitative	observation	 (Figure	
S5b).	Additionally,	we	explored	classical	senescence	biomarkers	such	
as	IL‐6,	p21,	and	p53.	Similar	to	serum	levels	of	IL‐6,	cardiac	tissues	
showed	 increased	 IL‐6	 protein	 levels	 in	 old	mice,	 accompanied	 by	
increased	p21	and	phospho‐p53	protein	levels	compared	with	young	
mice	in	WT	and	KO	mice;	however,	there	was	a	higher	increase	in	old	
KO	mice	than	WT	mice	(Figure	S6).
To gain insight into metabolic “longevity regulatory” path‐
ways,	 we	 investigated	 IGF‐1,	 PI3K,	 mTOR	 in	 the	 heart.	 Since	
NLRP3−/−	 mice	 showed	 low	 levels	 of	 IGF‐1	 in	 young	 and	 old	
F I G U R E  3  Telomere	length	diferentes	in	cardiac	cells	from	WT	and	NLRP3	−/−	mice.	(a)	Representative	confocal	images	of	telomere	Q‐
FISH	and	PCM1	immunofluorescence	of	cardiac	tissue	from	young	and	old	WT	and	NLRP3−/−	mice.	Orange	arrowheads	indicate	PCM1+	
cardiomyocytes.	White	arrowheads	indicate	PCM1−	noncardiomyocytes.	Dashed	lines	encircle	telomere	signals	in	those	cardiac	cells.	Bars,	
10	µm.	(b)	Telomere	length	distribution	in	total	cardiac	cells	(left)	and	cardiomyocytes	(right)	of	young	and	old	WT	and	NLRP3−/−	mice.	
Vertical	lines	indicate	mean	length	(***p	<	.001,	Wilconxon's	rank‐sum	test)
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F I G U R E  4  Changes	in	the	Pi3K/mTOR	pathways	and	autophagy	observed	in	cardiac	tissues	from	young	and	old	mice.	(a)	Western	blot	
analysis	showing	reduced	levels	in	the	Pi3K/mTOR	pathway	in	the	heart	of	NLRP3	−/−	mice	compared	with	WT.	Densitometric	analysis	
are	presented	as	means	±	SEM, n = 10 mice; ***p < .001 young vs. old mice. aaap	<	.001,	WT	vs.	NLRP3	−/−	mice.	(b)	Western	blot	analysis	
with	representative	blot	including	ATG12,	Beclin	1,	LC3,	Parkin,	and	p62	level	in	the	heart	of	Young	and	old	mice.	Densitometric	analysis	
are	presented	as	means	±	SEM, n = 10 mice; *p < .05, **p < .005, and ***p < .001 young vs. old mice. (c) Cardiac tissues showing typical 
ultrastructure with several lamellar bodies and autophagosome (black arrows) present in cardiac tissues from old mice and (white arrows). 
Scale	bar	2	µm	(low	magnification)	and	1	µm	(high	magnification)
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mice, we examined signaling changes through these pathways in 
the heart. Despite no significant differences in phosphorylation 
of PI3K (p110α),	mTOR	 (Ser2448)	was	decreased	 in	 the	heart	of	
aged	NLRP3−/−	mice	 (Figure	4a).	These	data	are	consistent	with	
the previous observations that cardiac aging is retarded and that 
healthspan	is	increased	by	mTOR	inhibition	(Inuzuka	et	al.,	2009;	
Wu	et	al.,	2013).	mTOR	inhibition	is	associated	with	the	important	
physiological	process	of	lysosomal‐dependent	recycling,	known	as	
autophagy, which is involved in cellular homeostasis through pro‐
tein degradation and removal of damaged intracellular organelles 
(Pyo	et	al.,	2013).	Autophagic	disfunction	has	also	been	linked	to	
aging with blocked autophagic flux and accumulation of nondegra‐
dated substrates in the form of autophagosome (Pyo et al., 2013). 
Interestingly,	NLRP3−/−	mice	showed	increased	levels	of	ATG12,	
beclin	1	expression,	and	LC3II	protein	expression	in	NLRP3−/−	old	
mice,	with	a	reduction	of	p62/SQSTM1	(Figure	4b).	From	electron	
microscopic analysis, we corroborated that the numbers of accu‐
mulated	autophagosomes	were	reduced	in	hearts	from	NLRP3−/−	
old mice (Figure 4c). This could be explained by where NLRP3 
inhibition	induced	improved	autophagy	quality	in	the	heart	during	
aging.
2.4 | Age‐associated change of the cardiac gene 
expression profile was prevented in NLRP3 −/− mice
To better define the molecular basis of improved cardiac health in 
the absence of NLRP3, a microarray expression profiling was per‐
formed	 on	 cardiac	 tissues	 obtained	 from	 22‐month‐old	 animals.	
In	old	WT	mice,	202	transcripts	 (from	the	65,956	transcripts	ex‐
amined)	changed	significantly	when	compared	with	old	NLRP3−/−	
mice: 142 transcripts were upregulated and 60 transcripts were 
downregulated,	 as	 those	 with	 a	 fold	 change	 equal	 to	 or	 higher	
F I G U R E  5  Transcriptional	changes	in	heart	from	Young	and	old	WT	and	NLRP3	−/−	mice.	Gene	Ontology	enrichment	analysis	in	
“Biological	Process”	in	WT	young	vs.	old	mice	(a),	NLRP3	−/−	Young	vs.	old	mice	(b),	and	WT	old	vs.	NLRP3	−/−	old	mice	(c).	(d)	Heatmap	
clustering	of	enrichment	(z‐scores)	of	the	functions	defined	by	the	DAVID	in	set	of	coding	genes	differentially	expressed	between	WT	old	vs.	
NLRP3	−/−	old	mice	(n = 3 per treatment)
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than	2,	and	a	p‐value	equal	to	or	lower	than	0.05	(Figure	S7a).	The	
most	significant	changes	common	to	aging	 in	WT	and	NLRP3−/−	
mice are available at http://www.ncbi.nlm.nih.gov/geo/ with code 
GSE12	4483.	All	the	gene	expression	data	were	loaded	into	DAVID	
for	gene	ontology	(GO)	enrichment	analysis.	The	enrichment	anal‐
ysis	in	WT	young‐to‐old	mice	showed	that	for	the	biological	pro‐
cess, most of the genes were enriched in the response to stress 
and organic substances. However, these and other important bio‐
logical and molecular enriched processes were not significantly 
different	 from	 those	 in	 NLRP3−/−	 young	 and	 old	 mice.	 NLRP3	
deletion conferred protection related to aging, and significant dif‐
ferences	were	 found	 between	WT	 and	NLRP3−/−	 (Figure	 5a–c).	
To examine the differences in gene expression profiling, gene 
coding pathways were represented in a heatmap (Figure 5d). Our 
analysis indicated that 43 pathways were significantly altered be‐
tween	old	WT	and	old	NLRP3−/−	mice.	For	a	deeper	analysis,	the	
downregulated changes in protein coding are presented in Table 
S3	 and	 the	 upregulated	 changes	 are	 summarized	 in	 Table	 S4.	 A	
subset of expression changes was verified by polymerase chain 
reaction	with	reverse	transcription	(RT‐qPCR)	(Figure	S8).	Notably,	
the	 most	 significant	 downregulated	 gene	 expression	 in	 old	WT	
mice compared with old NLRP3 was nicotinamide phosphoribosyl‐
transferase	(Nampt),	the	rate‐limiting	enzyme	in	mammalian	NAD+ 
biosynthesis	(Table	S2).	NAD+ deficiency is suggested to be a com‐
mon central pathological factor in a number of diseases, including 
cardiovascular	diseases	and	aging	(North	&	Sinclair,	2012;	Zhang	
&	Ying,	2018).	 Interestingly,	Nampt‐mediated	NAD+ deficiency is 
severely associated with glucose intolerance and insulin resist‐
ance	in	metabolic	dysfunction	by	a	high‐fat	diet	(HFD)	and	aging	
(Yoshino,	Mills,	Yoon,	&	 Imai,	2011).	Accordingly,	we	determined	
NAD+ levels from the heart during HFD and a high sucrose diet 
(HSD)	 (exposed	15	weeks)	and	aging	 in	WT	and	NLRP3−/−	mice.	
In	this	respect,	NLRP3−/−	mice	showed	increased	NAD+ levels in 
both	cases	(HFD,	HSD,	and	aging)	and	increased	SIRT‐1	protein	ex‐
pression	(Figure	S9A,B).	These	findings	could	explain	the	improved	
metabolic	status	and	autophagic	flux	observed	in	NLRP3−/−	mice	
during aging (Fang et al., 2017).
The	 homocysteine	 inducible	 ER	 protein	 with	 ubiquitin‐like	
domain 1 (Herpud1), which has been proposed as necessary for 
adequate	 insulin‐induced	 glucose	 uptake	 (Navarro‐Marquez	 et	
al.,	2018),	was	also	shown	to	be	downregulated	 in	old	WT	when	
compared	 to	old	NLRP3	−/−	mice	 (Table	S2).	Herpud1	 inhibition	
has recently been associated with induced pathological cardiac 
hypertrophy, which could explain the reduced hypertrophy ob‐
served	 in	NLRP3	−/−	mice	 (Torrealba	 et	 al.,	 2017).	 Similarly,	 our	
transcriptomic study showed upregulated gene expression of the 
cardiac	hypertrophy‐related	gene.	Expression	of	established	bio‐
markers	atrial	natriuretic	peptide	A	(Nppa)	and	B	(Nppb),	which	are	
associated with cardiac hypertrophy and strongly upregulated in 
the	ventricular	myocardium	during	cardiac	stress	(Man,	Barnett,	&	
Christoffels,	2018;	Newman,	Nguyen,	Watson,	Hull,	&	Yu,	2017),	
significantly	 increased	 in	 old	WT	mice	when	 compared	with	 old	
NLRP3	mice.	Acta1	was	the	second	most	upregulated	gene	in	old	
WT	mice	when	compared	with	old	NLRP3−/−	mice.	Recently,	Acta1	
has been associated with cardiac hypertrophy through increased 
levels	of	IGF‐1,	so	the	reduced	levels	of	Acta1	in	NLRP3−/−	mice	
could	be	associated	with	the	reduced	serum	levels	of	IGF‐1	shown	
in this study (Bisping et al., 2012). The insulin receptor substrate 
protein	1	(IRS‐1)	was	also	upregulated	in	old	WT	mice	when	com‐
pared	 to	 old	NLRP3−/−	mice.	 IRS‐1	may	 contribute	 to	 longevity	
(Selman,	Partridge,	&	Withers,	2011).
Rad	(Ras	associated	with	diabetes)	GTPase	has	been	established	
as	an	endogenous	regulator	of	cardiac	excitation‐contraction	(Wang	
et	 al.,	 2010).	 Rrad	 gene	 expression	was	 increased	 in	WT,	 but	 not	
in	 old	 NLRP3−/−	mice,	 which	 could	 explain	 the	 increased	 cardiac	
pathology. Moreover, upregulation of Thbs1 was also observed in 
old	WT	mice	when	compared	with	NLRP3−/−	mice,	which	is	associ‐
ated with a disturbed flow from arterial stiffening (Kim et al., 2017). 
Tumor necrosis factor receptor superfamily member 12a (Tnfrsf12a) 
and tripartite motif containing 72 (TRIM72) overexpression have 
been associated with atherosclerosis and diabetic cardiomyopathy, 
respectively (Liu et al., 2015; Lyu et al., 2018).
Accordingly,	 these	 genes	 were	 upregulated	 in	 old	 WT	 mice	
compared	with	NLRP3−/−	mice,	supporting	the	enhancing	role	of	
NLRP3 inhibition in the cardiovascular aging process. Furthermore, 
the	expression	of	transglutaminase	2	(TGM2),	an	arterial	calcifica‐
tion‐related	protein	that	is	positively	associated	with	hypertension	
and	 atherosclerosis	 (Mattison	 et	 al.,	 2014),	 and	Collagen	 type	 IV	
alpha1	(COL4A1)	and	alpha2	(COL4A2)	linked	to	the	pathogenesis	
of	vascular	lesions	were	increased	in	WT	but	not	in	NLRP3−/−	mice	
(Jeanne,	 Jorgensen,	&	Gould,	2015).	Collectively,	 these	data	sup‐
port significant protection imparted by NLRP3 inhibition on car‐
diac	aging	and	age‐induced	stress	and	vascular	changes	that	occur	
during aging. Furthermore, this microarray study showed upreg‐
ulation	of	 genes	 associated	with	 the	mTOR	pathway	 (Arntl,	Akt1	
and	Ddit4)	from	old	WT	mice	and	changes	associated	with	the	neg‐
ative	 regulation	of	autophagy	processes	 (Nampt,	Stat3,	Fez2	and	
Akt1),	which	are	associated	with	our	findings	of	an	inhibited	mTOR	
pathway	and	increased	autophagy	in	NLRP3	−/−	mice	during	aging	
(Table	S2	and	S3).
Several	of	the	metabolic	changes	presented	in	this	study	corrobo‐
rated	a	special	protection	for	cardiac	changes	by	NLRP3−/−	deletion.	
The metabolic hallmarks related to aging such as glucose tolerance 
and	 lipid	metabolism	 are	 potentially	 corrected	 in	NLRP3−/−	mice,	
probably	related	to	the	reduced	IGF‐1	signaling	and	the	PI3K/AKT/
mTOR pathway. Notably, adiponectin was also increased in these 
mice	during	aging.	Adiponectin	has	been	shown	to	have	beneficial	
cardiovascular effects and to signal through the adiponectin recep‐
tors,	AdipoR1	and	AdipoR2	(Lindgren	et	al.,	2013).	AdipoR2−/−	mice	
were	 resistant	 to	obesity	 induced	by	a	high‐fat	diet	 and	exhibited	
improved glucose tolerance and decreased plasma cholesterol levels 
(Fontana,	Vinciguerra,	&	Longo,	2012).	Increased	levels	of	AdipoR2	
were	 observed	 in	 old	 WT	 mice	 when	 compared	 with	 NLRP3−/−,	
which	could	be	associated	with	AdipoR2	deficiency‐dependent	pro‐
tection of atherosclerosis (Lindgren et al., 2013). Furthermore, the 
reduced levels of adiponectin associated with increased levels of 
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AdipoR2	in	WT	mice	in	aging	could	be	interpreted	as	an	attempt	to	
contribute	to	the	optimization	of	their	metabolic	environment.	This	
has a negative effect, increasing the leptin/adiponectin ratio.
3  | DISCUSSION
Aging	 is	 the	principal	pathological	process	of	cardiovascular	dis‐
eases	 in	healthy	people.	The	principal	age‐dependent	changes	 in	
cardiac structure and function in the heart during normal aging 
are not well understood and, if defined, could provide new clues 
for	protection	from	aging‐specific	cardiac	functional	decline.	This	
study showed that NLRP3 is associated with aging by an improved 
lifespan and healthspan via the modification of several hallmarks 
of aging. Little has been studied about the role of NLRP3 inhibition 
during aging, and nothing has been studied about longevity; our 
data, such as glucose tolerance, are consistent with previous stud‐
ies on the effect of NLRP3 ablation on aging (Youm et al., 2013). 
Inflammation	 is	highly	associated	with	aging	and	age‐related	dis‐
eases	 and	many	 rejuvenation	 strategies	 adopt	 anti‐inflammatory	
diets (Finkel, 2015; Fontana et al., 2012). Increased systemic in‐
flammation is commonly concomitant with metabolic alterations 
and the deterioration of metabolic health, including the appear‐
ance of increased adiposity, insulin resistance, and dyslipidemia, 
which could prove to be a key determinant of a shortening lifespan 
and	healthspan	 (Finkel,	 2015).	According	 to	 this,	 one	 should	 an‐
ticipate that an experimental manipulation of a specific inflamma‐
tory pathway would entail systemic and metabolic effects with an 
improvement in life expectancy and health. Our results provide 
convincing evidence that the NLRP3 ablation causes an increase 
in longevity that could be due to several of the metabolic changes 
induced by this manipulation. In this study, we have observed an 
increase in glucose tolerance, a reduction and an increase, re‐
spectively, in lectin and adiponectin levels, and a regulation of 
dyslipemia.	All	 these	changes	are	associated	with	common	path‐
ways,	such	as	IGF‐1,	PI3K/AKT/mTOR,	autophagy,	and	intracellu‐
lar	NAD+	levels	(Finkel,	2015).	According	to	our	data,	the	ablation	
of	NLRP3	showed	low	serum	levels	of	IGF‐1	in	old	mice.	The	role	
of	 the	 protective	 pathological	 effects	 of	 IGF‐1	 is	 contradictory,	
but	our	data	suggest	 that	 low	serum	 levels	of	 IGF‐1	are	 the	end	
product	 of	 decreased	 insulin/IGF‐1	 signaling,	which	 is	 known	 to	
prolong life, both in invertebrates and in vertebrates (Finkel, 2015; 
Fontana	et	al.,	2012).	Thus,	low	levels	of	insulin	and/or	IGF‐1	sign‐
aling,	along	with	a	high	sensitivity	to	insulin	and	IGF‐1,	are	physio‐
logical	characteristics	that	support	the	prolonged	lifespan	of	Ames	
dwarf	mice	 (Finkel,	2015)	 in	which	the	 levels	of	 IRS‐1	associated	
with	 longevity	were	 reduced	 (Papaconstantinou	&	Hsieh,	 2015).	
Interestingly,	 our	 transcriptomic	 analysis	 showed	 reduced	 IRS‐1	
expression	in	old	NLRP3	mice	when	compared	to	old	WT	mice.
NLRP3	ablation	also	showed	inhibition	of	PI3K/AKT/mTOR.	mTOR	
is	a	serine‐threonine	kinase	that	functions	as	an	intracellular	energy	
sensor whose genetic and pharmacological inhibition has been shown 
to	 extend	 life	 in	 a	 wide	 range	 of	 organisms	 (Cordero,	 Williams,	 &	
Ryffel,	2018;	Wu	et	al.,	2013).	Since	it	 is	known	that	mTOR	induces	
autophagy, the ablation of NLRP3 also showed, consistent with 
previous data showing the effect of inhibition of NLRP3 with other 
stressors, such as a hypercaloric diet, an increase in autophagy during 
aging	 (Pavillard	 et	 al.,	 2017).	 Cardiac	 aging	 is	 characterized	 by	 the	
presence of hypertrophy, fibrosis, and the accumulation of misfolded 
proteins and dysfunctional mitochondria. Therefore, autophagy and 
autophagic fluxes generally were reduced in cardiac tissues during 
aging, and models of loss of murine autophagy function models show 
an increase in cardiac dysfunction associated with the accumulation 
of	 misfolded	 proteins	 and	 dysfunctional	 organelles.	 Accordingly,	 it	
has been shown that the stimulation of autophagy improves cardiac 
function by eliminating accumulated cellular content, thus relieving 
different	aging‐associated	pathologies	in	the	heart	(Shirakabe,	Ikeda,	
Sciarretta,	Zablocki,	&	Sadoshima,	2016).	This	mechanism	could	be	key	
to the improvement of longevity and health induced by the inhibition 
of NLRP3 and the support of many of the strategies to improve the 
extension of lifespan and healthspan through the use of rapamycin, 
caloric restriction with metformin or resveratrol, which have two com‐
mon mechanisms: an improvement in autophagy and NLRP3 inhibition 
of inflammasome (Cordero et al., 2018). Furthermore, we found a re‐
duced	telomere	shortening	rate	in	WT	mice	when	compared	to	NLRP3	
−/−	mice.	Interestingly,	reductions	in	telomere	shortening	rate,	rather	
than the initial telomere length, have been suggested as a critical vari‐
able that determines a species’ lifespan in a wide variety of species, 
including	mice	and	humans	(Canela,	Vera,	Klatt,	&	Blasco,	2007;	Vera,	
Bernardes	 de	 Jesus,	 Foronda,	 Flores,	 &	 Blasco,	 2012;	Whittemore,	
Vera,	Martínez‐Nevado,	Sanpera,	&	Blasco,	2019).	We	also	found	that	
protein	 levels	of	 senescence/DNA	damage	markers,	 such	as	p21	or	
p53,	measured	by	Western	blot	increase	with	age	in	WT	hearts,	but	
their	expression	does	not	vary	with	age	in	NLRP3	−/−	hearts,	which	
could	 be	 related	 to	 a	 reduced	DNA	 damage	 response	 activated	 by	
dysfunctional	telomeres	in	these	animals.	Interestingly,	DNA	damage	
in dysfunctional telomeres is a key hallmark of cardiomyocytes with 
a	senescent‐like	phenotype	(Anderson	et	al.,	2019),	and	clearance	of	
senescence cells in mice alleviates cardiac deterioration with aging 
(Anderson	et	al.,	2019;	Lewis‐McDougall	et	al.,	2019).	Similarly,	inhibi‐
tion or deletion of NLRP3 would improve the detrimental effect of se‐
nescence cells in the heart, opening the door to a new line of research. 
In this sense, the NLRP3 inflammasome activation has been shown 
to promote the aging of the thymus and lead to immunosenescence 
(Spadaro	et	al.,	2016).	Moreover,	the	term	of	inflammaging	has	been	
nurtured	 and	 associated	with	 a	 low‐grade	 proinflammatory	 pheno‐
type	that	accompanies	aging	(Latz	&	Duewell,	2018).	The	different	im‐
plications of NLRP3 in metabolism during aging and the protective role 
of the inhibition of NLRP3 show a relevant role of this in inflammaging. 
In	this	respect,	NLRP3	−/−	mice	showed	increased	inflammatory	levels	
during aging and, despite this, cardiac aging was prevented by NLRP3 
deletion.	Senescence	influences	the	cellular	environment	through	the	
secretion of proinflammatory cytokines, proteases, and chemokines 
called	senescence‐associated	secretory	phenotype	 (SASP).	Since	ac‐
tivation	 of	 the	NLRP3	 system	 is	 a	 probable	 driver	 of	 SASP	 (Latz	&	
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Duewell, 2018), our findings could suggest a role of NLRP3 in the se‐
nescence phenotype during inflammaging.
Another	age‐related	mechanism	linked	to	autophagy	impairment	
is	the	intracellular	reduction	of	NAD+.	NAD+ is an electron acceptor 
in the mitochondrial electron transport chain that is also an essential 
substrate	for	NAD+‐dependent	enzymes,	such	as	sirtuins	and	poly	
ADP	ribose	polymerase	(Rajman,	Chwalek,	&	Sinclair,	2018).	NAD+ 
levels decrease with age due to Nampt downregulation, oxidative 
stress, inflammation, defective circadian rhythm, and accumulation 
of	DNA	damage.	Nampt,	 a	 key	enzyme	 in	 the	 salvage	pathway	of	
NAD+ biosynthesis, is downregulated in the heart in response to 
ischemia,	which	induces	a	decrease	in	NAD+ levels in the heart, in‐
hibition	of	autophagic	 flux,	 and	cell	death	 (Shirakabe	et	al.,	2016).	
Therefore,	 restoring	 NAD+ content by overexpressing Nampt or 
adding	NAD+ supplements restores the level of autophagy during 
ischemia and reduces the extent of myocardial infarction (Rajman 
et	al.,	2018).	We	observed	an	increased	level	of	Nampt	in	NLRP3−/−	
old	mice	by	transcriptomic	analysis,	which	was	corroborated	by	real‐
time	 PCR.	 This	 is	 probably	 connected	 to	 the	 high	 levels	 of	NAD+ 
observed	in	hearts	of	elderly	NLRP3−/−	mice	fed	with	hypercaloric	
diets.
We	acknowledge	the	limitations	of	using	male	mice	only.	On	the	
other hand, we have studied the effect of the NLRP3 ablation in the 
expression	of	several	markers	of	senescence	by	Western	blots;	how‐
ever, our results must be extended to detect the specific cell type 
using,	among	others,	gH2AX‐telomere	immuno	FISH	or	gH2AX‐PML	
colocalization	in	Immunofluorescence	and	IHC.	Thus,	future	investi‐
gations should account for the implication of other inflammasomes 
in aging and their modulation.
In conclusion, our findings suggest that NLRP3 inhibition atten‐
uates the harmful effects of cardiac aging and extends the lifespan 
in male mice. NLRP3 ablation improves metabolic characteristics 
related to aging, such as glucose tolerance, lipid metabolism, and 
leptin/adiponectin. These results could be associated with reduced 
IGF‐1	 signaling	 and	 the	 PI3K/AKT/mTOR	 pathway	 and	with	 auto‐
phagy activation. Our data associate the inhibition of NLRP3 with 
previous interventions against aging, such as caloric restriction, 
metformin, resveratrol or protein restriction, and involve levels of 
Nampt‐dependent	NAD+	and	SIRT1	(Cordero	et	al.,	2018).	 In	addi‐
tion, our transcriptomic results show a profile related to metabolic 
improvement	and	an	anti‐hypertrophic	effect	of	cardiac	protection.	
Finally, NLRP3 inhibition could be associated with a specific inflam‐
masome‐dependent	 inflammaging.	 Therefore,	 prevention	 of	 the	
aging process through multiple mechanisms by NLRP3 inhibition is 
likely to attenuate the associated decrease in cardiac function. Thus, 
it offers a promising goal for the prevention of cardiac aging.
4  | E XPERIMENTAL PROCEDURES
4.1 | Ethical statements
Animal	studies	were	performed	in	accordance	with	European	Union	
guidelines	(2010/63/EU)	and	the	corresponding	Spanish	regulations	
for the use of laboratory animals in chronic experiments (RD 53/2013 
on	the	care	of	experimental	animals).	All	experiments	were	approved	
by the local institutional animal care committee.
4.2 | Animals
For all experiments, only male mice were used. Young and old 
NLRP3−/−	 transgenic	 mice	 (C57BL/6J	 background)	 and	 WT/
NLRP3+/+ littermate controls, weighing 25–30 g, were main‐
tained	 on	 a	 regular	 12	 hr	 light/dark	 cycle.	 All	 groups	 had	 ad	 li‐
bitum access to their prescribed diet and water throughout the 
whole study. Body weight and food intake were monitored weekly. 
Animal	rooms	were	maintained	at	20–22°C	with	30%–70%	relative	
humidity.
4.3 | Mouse longevity study
Young	and	old	C57/BL6/J	and	NLRP3−/−	transgenic	mice	(C57BL/6J	
background), weighing 25–30 g, were maintained on a regular 12 hr 
light/dark	cycle.	Mice	were	housed	in	groups	of	four	to	eight	same‐
sex	littermates	under	specific	pathogen‐free	conditions.	Individuals	
were monitored daily and weighed monthly, but were otherwise left 
undisturbed	until	 they	died.	Survival	was	assessed	using	male	and	
female mice, and all animals were dead by the time of this report. 
Kaplan–Meier survival curves were constructed using known birth 
and death dates, and differences between groups were evaluated 
using the logrank test.
4.4 | Reagents
Monoclonal	 antibodies	 specific	 for	 Beclin‐1	 and	 p62	 were	 pur‐
chased	 from	 Sigma‐Aldrich.	 The	 anti‐GAPDH	 monoclonal	 an‐
tibody	 was	 acquired	 from	 Calbiochem‐Merck	 Chemicals	 Ltd.	
Similarly,	 anti‐active	 caspase‐3,	 anti‐SIRT‐1,	 p‐PI3K	 and	 PI3K,	
p‐mTOR	 and	 mTOR,	 and	 anti‐Parkin	 were	 obtained	 from	 Cell	
Signaling	 Technology.	 Finally,	 anti‐Bcl‐2,	 anti‐Bax,	 anti‐ATG12,	
and	 anti‐MAP‐LC3	 antibodies	 were	 obtained	 from	 Santa	 Cruz	
Biotechnology.	 A	 cocktail	 of	 protease	 inhibitors	 (Complete™	
Protease Inhibitor Cocktail) was purchased from Boehringer 
Mannheim.	The	Immun	Star	HRP	substrate	kit	was	obtained	from	
Bio‐Rad	Laboratories	Inc.
4.5 | Glucose tolerance test
Glucose	tolerance	tests	were	performed	by	fasting	the	mice	over‐
night for 16 hr and then injecting glucose (1 g/kg), intraperitoneally. 
Glucose	 measurements	 were	 performed	 using	 a	 Bayer	 Contour	
blood glucose meter and test strips.
4.6 | Leptin, adiponectin, and IGF‐1
Serum	levels	of	leptin,	adiponectin,	and	IGF‐1	were	assayed	in	dupli‐
cate	using	commercial	ELISA	kits	(R&D	Systems).
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4.7 | Serum biomarkers
Serum	 levels	of	glucose,	 triglycerides,	cholesterol,	uric	acid,	aspar‐
tate aminotransferase, alanine aminotransferase, and creatine ki‐
nase were assayed using commercial kits (Randox Laboratories).
4.8 | Immunoblotting
Western	 blotting	 was	 performed	 using	 standard	 methods.	 After	
protein transfer, the membrane was incubated with various primary 
antibodies diluted at 1:1,000 and then with the corresponding sec‐
ondary antibodies coupled to horseradish peroxidase at a 1:10,000 
dilution.	Specific	protein	complexes	were	identified	using	the	Immun	
Star	HRP	substrate	kit	(Biorad	Laboratories	Inc.).
4.9 | Electrocardiography
Mice	were	anesthetized	with	1.5%–2%	isoflurane	in	oxygen,	inhaled	
through	a	facial	mask.	To	avoid	night–day	circadian	variations,	ECG	
was	performed	in	the	morning.	ECG	electrodes	were	inserted	sub‐
cutaneously	in	the	four	limbs,	and	sequential	ECG	recordings	were	
acquired	 at	 2	 KHz	 sweep‐speed	 using	 a	 MP36R	 data	 acquisition	
workstation	(Biopac	Systems).	Data	were	stored	for	off‐line	analysis	
using custom MatLab scripts. In 3 and 20 months of age/ death of 
the	animal,	NLRP3−/−	and	WT	mice	were	given	a	weekly	β‐adrener‐
gic	challenge	with	isoproterenol	(i.v.	bolus	0.34	mg/kg).	ECG	traces	
were recorded at baseline, after challenge, and during recovery 
(10–25 min).
ECG	 recordings	 were	 analyzed	 offline	 using	 custom	 scripts	 for	
preprocessing,	 visualization	 and	 quantification	 of	 electrophysiologic	
intervals	and	heart	 rate	variability	markers.	After	band‐pass	 filtering	
between	0.5	and	250	Hz,	baseline	wander	was	 removed	using	a	bi‐
directional filtering strategy. Baseline drift removal is essential for 
morphological	analysis	of	T	waves.	Specifically:	 (a)	PR	intervals	were	
measured from the beginning or the P wave to the peak of the R wave; 
(b)	QRS	 intervals	were	measured	from	the	beginning	of	 the	Q	wave	
until	the	point	where	the	S	wave	crosses	the	baseline;	and	(c)	QT	inter‐
vals	were	measured	from	the	beginning	of	the	Q	wave	until	the	point	
where the T wave declined to 90% (T90) from the peak. Finite differ‐
ential methods and wavelet transform were used for fiducial point 
estimation.	R‐peak	detection	was	robustly	estimated	by	parabolic	fit‐
ting of the coiflet wavelet transform and detection of the maximum 
magnitude	point.	All	R	detections	were	supervised	to	validate	accuracy	
of	ECG	segmentations.	After	QRS	detection,	P	and	T	wave	segments	
were	extracted	using	adaptive	windowing,	depending	upon	beat‐to‐
beat	RR	changes.	After	segmentation	using	differential	methods,	both	
waves	were	low‐pass	filtered	at	20	Hz	using	a	Kaiser	window	FIR	filter.
4.10 | Echocardiography
Two‐dimensional	 and	 M‐mode	 echocardiography	 longitudi‐
nal	 studies	 were	 performed	 in	 3‐month	 intervals	 throughout	
the	mice's	 entire	 lifespan.	Males	 (n	 =	 10–15)	 were	 anesthetized	
(1.5%–2% isoflurane in a mixture with oxygen), and the analysis 
was	carried	out	using	a	Vevo770	system	(Vevo	2100,	Visualsonics	
Inc.)	 equipped	with	 a	30‐MHz	 linear	 transducer	 probe.	 To	 avoid	
night–day circadian variations, echocardiographs were performed 
in the mornings. Before echocardiography, animal fur was removed 
with a depilatory agent and animals were warmed to maintain 
body temperature. The heart was imaged in the 2D parasternal 
long‐	and	short‐axis	projections	with	guided	M‐mode	recordings	
at the midventricular level in both views. Images were recorded 
and transferred to a computer for posterior blinded analysis using 
the	Vevo	2100	Workstation	 software.	 LV	end‐diastolic	 diameter	
(LVEDD),	 LV‐systolic	 diameter	 (LVESD),	 end‐diastolic	 LV	 anterior	
wall	 thickness	 (LVAW),	 and	 LV	 posterior	 wall	 thickness	 (LVPW)	
were	 measured	 from	 images	 obtained	 with	 M‐mode	 echocardi‐
ography.	 LV	 fractional	 shortening	 (FS)	 and	 aortic	 cardiac	 output	
(AA.CO)	was	calculated.	LV	ejection	fraction	(EF)	by	the	Teichholz	
formula	 was	 assessed	 by	 using	 the	 M‐mode	 images	 displayed	
over	time	and	obtained	from	a	single	line	in	the	middle	of	LV.	The	
LV	mass	was	calculated	 from	the	same	M‐mode	 images	by	using	
diastolic	 LV	 diameters	 of	 LV	 internal	 diameter	 (LVID),	 posterior	
wall	 (PW),	 and	 interventricular	 septum	 (IVS)	 as	 follow:	 LV	Mass	
(mg)	 =	 1.05	 (Lid	 +	 LVPWd	+	 IVSd3	–	 LVIDd3)	 0.8.	Corrected	 LV	
Mass	=	(LV	Mass)	0.8.
4.11 | Histological study
After	anesthesia	of	mice,	hearts	were	excised	and	placed	in	a	16	mM	
KCl solution to arrest the heart in diastole prior to fixation and imme‐
diately	placed	in	10%	neutral‐buffered	formalin	at	room	temperature	
for	24	hr	after	a	brief	rinse	with	PBS.	The	specimens	were	embedded	
in	paraffin,	cut	into	5‐μm sections, and stained with hematoxylin and 
eosin.	To	detect	fibrosis	in	heart	sections,	consecutive	formalin‐fixed,	
paraffin‐embedded,	 4‐µm	 sections	 were	 stained	 with	 Masson	 tri‐
chrome	or	with	Sirius	Red.	Masson	trichrome	staining	was	performed	
following	 the	 manufacturer's	 instructions	 (Accustain	 HT15,	 Sigma‐
Aldrich).	Sirius	Red	staining	was	performed	by	incubating	slides	in	0.1%	
Sirius	Red	F3B	for	1	hr,	 rinsing	 twice	 in	acidified	water,	dehydrating	
thrice in 100% ethanol, and then clearing in xylene. Manually delimited 
cardiomyocyte or fibrotic areas were also calculated on a digital micro‐
scope	(×400)	with	ImageJ	(version	ImageJ	1.49)	software.
4.12 | Electron microscopy
Transmission	electron	microscopy	(TEM).	Mice	were	euthanized	by	
cervical dislocation and the left ventricle apex was immediately dis‐
sected (3 months old, n = 3 per genotype and 20 months old, n = 3 
per genotype). Heart samples were fixed in 2.5% glutaraldehyde and 
4%	 formaldehyde	 in	 0.1	M	HEPES	 buffer	 for	 4–5	 hr.	 After	 buffer	
washes, samples were postfixed for 1 hr at room temperature in a 
1:1	solution	of	1%	osmium	tetroxide	and	3%	aqueous	potassium	fer‐
rocyanide.	Samples	were	 rinsed	 in	distilled	H2O. Tissues were de‐
hydrated	through	a	graded	acetone	series	and	embedded	in	Spurr's	
low	 viscosity	 embedding	 mixture	 (Electron	 Microscopy	 Sciences).	
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Ultra‐thin	 sections	 (60	 nm)	 were	 then	 mounted	 on	 copper	 grids	
and	 stained	with	 lead	 citrate.	 Samples	were	 examined	 on	 a	 JEOL	
10‐10	electron	microscope	 through	1,500×,	5,000×,	40,000×,	and	
80,000× objectives. Mitochondrial morphometry, cristae area (2 im‐
ages, 5,000×, per animal), and lipid droplets (50 images, 5,000×, per 
animal)	were	segmented	manually	and	analyzed	using	Fiji	(http://fiji.
sc/Fiji)	and	ImageJ	1.48v	software.	The	investigator	was	blinded	to	
the group allocation when assessing the outcome.
4.13 | Telomere length analysis
The	 telomere	 length	 of	 cardiac	 cells	was	measured	 by	 quantita‐
tive	fluorescence	in	situ	hybridization	(Q‐FISH).	Hearts	were	fixed	
in	 4%	 PFA,	 and	 paraffin‐embedded	 tissue	 sections	 of	 the	 same	
thickness (4 μm) were first immunostained for PCM1 (1.300). 
Slides	were	then	fixed	in	4%	formaldehyde	for	2	min,	treated	with	
0.28	mM	pepsin	 for	 10	min	 at	 37°C	 and	 then	 hybridized	with	 a	
Cy3‐labeled	 peptide	 nucleic	 acid	 probe	 targeting	 the	 telomere	
repeat	 sequence	 (Flores	 et	 al.,	 2008).	 The	 intensity	 of	 the	 fluo‐
rescent signal for a given telomere is directly proportional to tel‐
omere	length,	providing	a	quantitative	measure	of	telomere	length	
(Lansdorp et al., 1996).
For	 telomere	 length	 analysis,	DAPI,	Cy3	 (telomeres),	 and	 im‐
munofluorescence	signals	were	acquired	sequentially	 in	separate	
channels	of	a	confocal	microscope	(SP5)	fitted	with	a	63×	objec‐
tive	and	 linked	to	LasAF	and	MatrixScreener	software.	All	 slides	
were	 stained	 at	 the	 same	 time,	 and	 all	 images	were	 acquired	 at	
the	 same	 laser	 intensity.	 For	 image	 quantification,	 Nikon	 NIS	
Elements software was used to subtract Cy3 channel background 
and	to	generate	maximum‐intensity	projections	from	16‐bit	image	
stacks	 (15	sections	at	steps	of	1.0	µm).	Quantitative	 image	anal‐
ysis was performed using the Metamorph platform as previously 
described	 (Flores	 et	 al.,	 2008).	 The	DAPI	 images	were	 signal‐in‐
tensity	thresholded.	After	conversion	to	a	1‐bit	binary	mask,	the	
DAPI	image	was	used	to	define	the	nuclear	area	and	the	Cy3	image	
to	quantify	telomere	fluorescence.	The	binary	DAPI	mask	was	ap‐
plied to the Cy3 image to obtain a combined image with the telo‐
mere fluorescence information for each nucleus. Cy3 fluorescence 
intensity was measured as the mean gray value in each nucleus 
in arbitrary units of fluorescence (auf). Telomere intensity values 
were exported to Excel. For the determination of telomere length 
in cardiomyocytes, cardiomyocyte nuclei were manually selected 
with Metamorph using the PCM1 immunofluorescence images. 
Only cells clearly identifiable as cardiomyocytes were considered 
for the analysis.
4.14 | Transcriptome analysis
We	used	the	Affymetrix	clariomTM D assay mouse, which includes 
65,956	 genes.	 The	 raw	 data	 were	 analyzed	 by	 the	 Affymetrix	
software	 Trancriptome	 Analysis	 Console.	 Expression	 values	 were	
normalized	 by	 SST	 (Signal	 Space	 Transformation)‐RMA	 (Robust	
Microarray	Analysis;	Irizarry	et	al.,	2003),	and	the	mutant	mice	were	
compared	vs.	WT,	using	the	3	replicates	for	every	analysis.	Then,	a	
fold	change	and	p‐value	were	calculated	for	every	gene	by	an	un‐
paired	 test	 one‐way	 (single	 factor)	 using	 the	 NMATH	 package.	 A	
gene was considered as differentially expressed when it had a fold 
change	equal	to	or	higher	than	1.5,	and	a	p‐value	equal	to	or	lower	
than	0.05	using	Fisher's	exact	 test.	Then,	 a	 functional	enrichment	
was performed with the differentially expressed genes using the 
functional	annotation	tool	from	the	DAVID	web	site	(https	://www.
ncbi.nlm.nih.gov/pmc/artic	les/PMC33	81967/	).	As	such,	we	found	a	
number	of	annotation	categories.	To	analyze	the	expression	profile	
for the genes included in these categories, a heatmap was created 
for every annotation category, using the heatmap.2 function in the 
gplots	R	package,	and	considering	normalized	values	by	z‐scores,	and	
making a clustering based on the expression profiles and the average 
method. Finally, a mean of the expression values in every annotation 
category was calculated and it was again plotted in a heatmap.
4.15 | Quantification of intracellular NAD+
Total	NAD+ concentrations were determined independently in whole 
cardiac	 extracts	 using	 the	 NAD+	 cycling	 assay	 (Abcam	 ab65348,	
Inc.),	as	described	previously.	NAD+ levels were expressed as pmol/
mgprotein.
4.16 | Statistics
All	data	are	expressed	as	means	±	SEM.	After,	evaluation	of	normality	
using	the	Shapiro–Wilk	test,	statistical	differences	among	the	differ‐
ent	groups	were	measured	using	either	an	unpaired	Student	t test or 
1‐way	analysis	of	variance	(ANOVA)	when	appropriate	with	Tukeys	
post	hoc	test.	A	Wilcoxon's	ram	sum	test	was	used	to	calculate	the	
statistical	significance	between	telomere	 length	distributions.	A	p‐
value	of	≤.05	was	considered	statistically	significant.	Statistical	anal‐
yses	were	performed	using	Prism	software	version	5.0a	(GraphPad).	
Asterisks	in	the	figures	represent	the	following:	*:	p	≤	.05;	**:	p	≤	.01;	
and ***: p	≤	.001.
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